C-Reactive Protein and Body Fat, The Missing Link to Heart Disease?
Researchers at The University of Texas M. D. Anderson Cancer Center and The University of Texas Health Science Center in Houston have found that human fat cells produce C-reactive protein (CRP), which is linked to both inflammation and an increased risk of heart disease and stroke. The researchers believe this explains why those who are overweight have a higher risk of developing both of these health problems.
In recent years body fat has been studied as an organ in itself, capable of producing a number of different biologically active molecules. These molecules include inflammatory proteins called cytokines, and the hormone resistin, which is linked to insulin resistance and the development of type 2 diabetes. Overweight people, even those who are healthy, tend to have higher levels of CRP in their blood, but until now researchers had very little understanding as to why this is true.
"This study is the first to show how body fat participates in the inflammatory process that leads to cardiovascular disease," said study leader Edward T. H. Yeh, M.D., who is both chairman of the Department of Cardiology at M. D. Anderson and director of the Research Center for Cardiovascular Disease at the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases at the UT Health Science Center at Houston. Dr. Yeh's team had previously discovered that CRP is manufactured in the walls of blood vessels, but with this study they were attempting to make the connection between obesity and higher CRP levels.
Dr. Yeh's team decided to see whether fat cells themselves are stimulated by the inflammatory cytokines or resistin to produce CRP. They recruited plastic surgery patients to donate fatty tissue that would have been discarded after their surgery. They then removed the fat cells, cultured them and stimulated them under a number of different conditions. They discovered the fat cells produced cytokines, resulting in inflammation. This inflammation in turn triggered an increased production of CRP. They also learned that resistin, which is produced by fat cells, could stimulate CRP production.
"We know that patients (who are overweight) have higher levels of CRPs, as well as a higher risk of developing heart disease and stroke, but no one understands why that is," Yeh said. "If fat cells by themselves produce inflammatory signals that trigger cells to produce CRPs, and if CRPs also produce biological effects on vascular walls, that could explain the higher risk of cardiovascular disease."
Dr. Yeh's team also discovered why aspirin, the statin drugs, and a medication for diabetes (troglitazone) help to reduce CRP levels. Because the researchers knew from other studies that these drugs reduced CRP levels in patients, they exposed the cultured fat cells that were producing higher CRP levels to these medications and measured CRP decline. This gave them direct proof that these drugs affect CRP production at the cellular level.
Dr. Yeh points out that there is still much that isn't known about CRP, including why fat cells produce inflammation and how CRP participates in that process, but the team is encouraged by the proof that currently used medications can prevent the damage that results from the inflammatory process.
This research provides us with some interesting information about the role of CRP. From a clinician's standpoint I believe that I have one more piece of evidence for individuals when discussing their need to take an aspirin, a statin drug, and a glitazone when managing obesity, heart disease, and diabetes risk. It doesn't tell us yet when an elevated CRP level is high enough to be concerned, or if an elevated level is the same regardless of an individual's gender or ethnicity. But that's info for another post :>)
Laurie
As I see it, every day you do one of two things: build health or produce disease in yourself.
Adelle Davis, health and fitness author
Related Topics: WebMD Video: How 'Microbubbles' Can Help Your Heart, 4 Heart Risks Facing American Women
Technorati Tags: heartdisease, bodyfat, c-reactiveprotein, aspirin
In recent years body fat has been studied as an organ in itself, capable of producing a number of different biologically active molecules. These molecules include inflammatory proteins called cytokines, and the hormone resistin, which is linked to insulin resistance and the development of type 2 diabetes. Overweight people, even those who are healthy, tend to have higher levels of CRP in their blood, but until now researchers had very little understanding as to why this is true.
"This study is the first to show how body fat participates in the inflammatory process that leads to cardiovascular disease," said study leader Edward T. H. Yeh, M.D., who is both chairman of the Department of Cardiology at M. D. Anderson and director of the Research Center for Cardiovascular Disease at the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases at the UT Health Science Center at Houston. Dr. Yeh's team had previously discovered that CRP is manufactured in the walls of blood vessels, but with this study they were attempting to make the connection between obesity and higher CRP levels.
Dr. Yeh's team decided to see whether fat cells themselves are stimulated by the inflammatory cytokines or resistin to produce CRP. They recruited plastic surgery patients to donate fatty tissue that would have been discarded after their surgery. They then removed the fat cells, cultured them and stimulated them under a number of different conditions. They discovered the fat cells produced cytokines, resulting in inflammation. This inflammation in turn triggered an increased production of CRP. They also learned that resistin, which is produced by fat cells, could stimulate CRP production.
"We know that patients (who are overweight) have higher levels of CRPs, as well as a higher risk of developing heart disease and stroke, but no one understands why that is," Yeh said. "If fat cells by themselves produce inflammatory signals that trigger cells to produce CRPs, and if CRPs also produce biological effects on vascular walls, that could explain the higher risk of cardiovascular disease."
Dr. Yeh's team also discovered why aspirin, the statin drugs, and a medication for diabetes (troglitazone) help to reduce CRP levels. Because the researchers knew from other studies that these drugs reduced CRP levels in patients, they exposed the cultured fat cells that were producing higher CRP levels to these medications and measured CRP decline. This gave them direct proof that these drugs affect CRP production at the cellular level.
Dr. Yeh points out that there is still much that isn't known about CRP, including why fat cells produce inflammation and how CRP participates in that process, but the team is encouraged by the proof that currently used medications can prevent the damage that results from the inflammatory process.
This research provides us with some interesting information about the role of CRP. From a clinician's standpoint I believe that I have one more piece of evidence for individuals when discussing their need to take an aspirin, a statin drug, and a glitazone when managing obesity, heart disease, and diabetes risk. It doesn't tell us yet when an elevated CRP level is high enough to be concerned, or if an elevated level is the same regardless of an individual's gender or ethnicity. But that's info for another post :>)
Laurie
As I see it, every day you do one of two things: build health or produce disease in yourself.
Adelle Davis, health and fitness author
Related Topics: WebMD Video: How 'Microbubbles' Can Help Your Heart, 4 Heart Risks Facing American Women
Technorati Tags: heartdisease, bodyfat, c-reactiveprotein, aspirin


